Skip to Main Content

Paper Details

Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer.
ESMO Open
3
2023
Author NameAffiliation
Charles M RudinMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2